Ernexa Therapeutics Inc. (ERNAW) Operating margin 2016–2025
Ernexa Therapeutics Inc. (ERNAW) operating margin by fiscal year — reported operating income divided by reported revenue.
-1601.2%FY2025 · since FY2016: -9.3% → -1601.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1601.2% | +21448.8 pp |
| FY2024 | -23050.0% | — |
| FY2021 | -1960.9% | -1924.3 pp |
| FY2020 | -36.6% | -29.0 pp |
| FY2019 | -7.6% | -8.5 pp |
| FY2018 | 1.0% | +7.2 pp |
| FY2017 | -6.3% | +3.0 pp |
| FY2016 | -9.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ERNAW financial trends
ERNAW RevenueERNAW Net incomeERNAW Net marginERNAW Gross profitERNAW Gross marginERNAW Operating incomeERNAW Operating cash flowERNAW Free cash flowERNAW Capital expendituresERNAW Return on equityERNAW Stock buybacksERNAW Dividends paidERNAW Total assetsERNAW Total liabilitiesERNAW Shareholders’ equityERNAW overview →